nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—prostate cancer—testicular cancer	0.906	1	CtDrD
Degarelix—Feeling abnormal—Ifosfamide—testicular cancer	0.000149	0.00158	CcSEcCtD
Degarelix—Nausea—Vinblastine—testicular cancer	0.000148	0.00158	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000147	0.00157	CcSEcCtD
Degarelix—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000147	0.00157	CcSEcCtD
Degarelix—Discomfort—Etoposide—testicular cancer	0.000147	0.00156	CcSEcCtD
Degarelix—Breast disorder—Epirubicin—testicular cancer	0.000147	0.00156	CcSEcCtD
Degarelix—Hypotension—Cisplatin—testicular cancer	0.000145	0.00154	CcSEcCtD
Degarelix—Hypersensitivity—Dactinomycin—testicular cancer	0.000145	0.00154	CcSEcCtD
Degarelix—Abdominal discomfort—Methotrexate—testicular cancer	0.000144	0.00153	CcSEcCtD
Degarelix—Muscular weakness—Epirubicin—testicular cancer	0.000143	0.00152	CcSEcCtD
Degarelix—Urticaria—Ifosfamide—testicular cancer	0.000143	0.00152	CcSEcCtD
Degarelix—Abdominal pain—Ifosfamide—testicular cancer	0.000142	0.00151	CcSEcCtD
Degarelix—Body temperature increased—Ifosfamide—testicular cancer	0.000142	0.00151	CcSEcCtD
Degarelix—Anaphylactic shock—Etoposide—testicular cancer	0.000142	0.00151	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000142	0.0015	CcSEcCtD
Degarelix—Asthenia—Dactinomycin—testicular cancer	0.000141	0.0015	CcSEcCtD
Degarelix—Dysuria—Methotrexate—testicular cancer	0.00014	0.00149	CcSEcCtD
Degarelix—Dyspnoea—Cisplatin—testicular cancer	0.000139	0.00147	CcSEcCtD
Degarelix—Skin disorder—Etoposide—testicular cancer	0.000138	0.00147	CcSEcCtD
Degarelix—Erectile dysfunction—Methotrexate—testicular cancer	0.000138	0.00147	CcSEcCtD
Degarelix—Hyperhidrosis—Etoposide—testicular cancer	0.000138	0.00146	CcSEcCtD
Degarelix—Breast disorder—Doxorubicin—testicular cancer	0.000136	0.00144	CcSEcCtD
Degarelix—Decreased appetite—Cisplatin—testicular cancer	0.000135	0.00143	CcSEcCtD
Degarelix—Diarrhoea—Dactinomycin—testicular cancer	0.000135	0.00143	CcSEcCtD
Degarelix—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000134	0.00142	CcSEcCtD
Degarelix—Vomiting—Bleomycin—testicular cancer	0.000134	0.00142	CcSEcCtD
Degarelix—Depression—Methotrexate—testicular cancer	0.000133	0.00142	CcSEcCtD
Degarelix—Hypotension—Etoposide—testicular cancer	0.000133	0.00141	CcSEcCtD
Degarelix—Rash—Bleomycin—testicular cancer	0.000133	0.00141	CcSEcCtD
Degarelix—Pain—Cisplatin—testicular cancer	0.000133	0.00141	CcSEcCtD
Degarelix—Dermatitis—Bleomycin—testicular cancer	0.000133	0.00141	CcSEcCtD
Degarelix—Hypersensitivity—Ifosfamide—testicular cancer	0.000133	0.00141	CcSEcCtD
Degarelix—Muscular weakness—Doxorubicin—testicular cancer	0.000132	0.00141	CcSEcCtD
Degarelix—Renal failure—Methotrexate—testicular cancer	0.000131	0.0014	CcSEcCtD
Degarelix—Dysuria—Epirubicin—testicular cancer	0.000131	0.00139	CcSEcCtD
Degarelix—Pollakiuria—Epirubicin—testicular cancer	0.00013	0.00138	CcSEcCtD
Degarelix—Asthenia—Ifosfamide—testicular cancer	0.000129	0.00137	CcSEcCtD
Degarelix—Feeling abnormal—Cisplatin—testicular cancer	0.000128	0.00136	CcSEcCtD
Degarelix—Weight increased—Epirubicin—testicular cancer	0.000128	0.00136	CcSEcCtD
Degarelix—Pruritus—Ifosfamide—testicular cancer	0.000128	0.00135	CcSEcCtD
Degarelix—Weight decreased—Epirubicin—testicular cancer	0.000127	0.00135	CcSEcCtD
Degarelix—Dyspnoea—Etoposide—testicular cancer	0.000127	0.00135	CcSEcCtD
Degarelix—Hyperglycaemia—Epirubicin—testicular cancer	0.000127	0.00134	CcSEcCtD
Degarelix—Hepatobiliary disease—Methotrexate—testicular cancer	0.000126	0.00134	CcSEcCtD
Degarelix—Nausea—Bleomycin—testicular cancer	0.000125	0.00133	CcSEcCtD
Degarelix—Vomiting—Dactinomycin—testicular cancer	0.000125	0.00133	CcSEcCtD
Degarelix—Rash—Dactinomycin—testicular cancer	0.000124	0.00132	CcSEcCtD
Degarelix—Decreased appetite—Etoposide—testicular cancer	0.000124	0.00131	CcSEcCtD
Degarelix—Diarrhoea—Ifosfamide—testicular cancer	0.000123	0.00131	CcSEcCtD
Degarelix—Renal failure—Epirubicin—testicular cancer	0.000123	0.00131	CcSEcCtD
Degarelix—Gastrointestinal disorder—Etoposide—testicular cancer	0.000123	0.00131	CcSEcCtD
Degarelix—Body temperature increased—Cisplatin—testicular cancer	0.000123	0.0013	CcSEcCtD
Degarelix—Fatigue—Etoposide—testicular cancer	0.000123	0.0013	CcSEcCtD
Degarelix—Constipation—Etoposide—testicular cancer	0.000122	0.00129	CcSEcCtD
Degarelix—Pain—Etoposide—testicular cancer	0.000122	0.00129	CcSEcCtD
Degarelix—Urinary tract infection—Epirubicin—testicular cancer	0.000122	0.00129	CcSEcCtD
Degarelix—Dysuria—Doxorubicin—testicular cancer	0.000121	0.00129	CcSEcCtD
Degarelix—Pollakiuria—Doxorubicin—testicular cancer	0.00012	0.00127	CcSEcCtD
Degarelix—Dizziness—Ifosfamide—testicular cancer	0.000119	0.00127	CcSEcCtD
Degarelix—Urinary tract disorder—Methotrexate—testicular cancer	0.000119	0.00126	CcSEcCtD
Degarelix—Hepatobiliary disease—Epirubicin—testicular cancer	0.000118	0.00126	CcSEcCtD
Degarelix—Weight increased—Doxorubicin—testicular cancer	0.000118	0.00125	CcSEcCtD
Degarelix—Urethral disorder—Methotrexate—testicular cancer	0.000118	0.00125	CcSEcCtD
Degarelix—Weight decreased—Doxorubicin—testicular cancer	0.000117	0.00125	CcSEcCtD
Degarelix—Feeling abnormal—Etoposide—testicular cancer	0.000117	0.00125	CcSEcCtD
Degarelix—Hyperglycaemia—Doxorubicin—testicular cancer	0.000117	0.00124	CcSEcCtD
Degarelix—Nausea—Dactinomycin—testicular cancer	0.000117	0.00124	CcSEcCtD
Degarelix—Gastrointestinal pain—Etoposide—testicular cancer	0.000116	0.00124	CcSEcCtD
Degarelix—Vomiting—Ifosfamide—testicular cancer	0.000115	0.00122	CcSEcCtD
Degarelix—Hypersensitivity—Cisplatin—testicular cancer	0.000114	0.00122	CcSEcCtD
Degarelix—Renal failure—Doxorubicin—testicular cancer	0.000114	0.00121	CcSEcCtD
Degarelix—Rash—Ifosfamide—testicular cancer	0.000114	0.00121	CcSEcCtD
Degarelix—Dermatitis—Ifosfamide—testicular cancer	0.000114	0.00121	CcSEcCtD
Degarelix—Urticaria—Etoposide—testicular cancer	0.000113	0.0012	CcSEcCtD
Degarelix—Body temperature increased—Etoposide—testicular cancer	0.000113	0.0012	CcSEcCtD
Degarelix—Abdominal pain—Etoposide—testicular cancer	0.000113	0.0012	CcSEcCtD
Degarelix—Urinary tract infection—Doxorubicin—testicular cancer	0.000113	0.0012	CcSEcCtD
Degarelix—Eye disorder—Methotrexate—testicular cancer	0.000112	0.00119	CcSEcCtD
Degarelix—Hypoaesthesia—Epirubicin—testicular cancer	0.000112	0.00119	CcSEcCtD
Degarelix—Asthenia—Cisplatin—testicular cancer	0.000111	0.00118	CcSEcCtD
Degarelix—Cardiac disorder—Methotrexate—testicular cancer	0.000111	0.00118	CcSEcCtD
Degarelix—Urinary tract disorder—Epirubicin—testicular cancer	0.000111	0.00118	CcSEcCtD
Degarelix—Oedema peripheral—Epirubicin—testicular cancer	0.000111	0.00118	CcSEcCtD
Degarelix—Urethral disorder—Epirubicin—testicular cancer	0.00011	0.00117	CcSEcCtD
Degarelix—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000109	0.00116	CcSEcCtD
Degarelix—Angiopathy—Methotrexate—testicular cancer	0.000109	0.00116	CcSEcCtD
Degarelix—Immune system disorder—Methotrexate—testicular cancer	0.000108	0.00115	CcSEcCtD
Degarelix—Mediastinal disorder—Methotrexate—testicular cancer	0.000108	0.00115	CcSEcCtD
Degarelix—Chills—Methotrexate—testicular cancer	0.000108	0.00114	CcSEcCtD
Degarelix—Nausea—Ifosfamide—testicular cancer	0.000107	0.00114	CcSEcCtD
Degarelix—Diarrhoea—Cisplatin—testicular cancer	0.000106	0.00113	CcSEcCtD
Degarelix—Alopecia—Methotrexate—testicular cancer	0.000106	0.00113	CcSEcCtD
Degarelix—Mental disorder—Methotrexate—testicular cancer	0.000105	0.00112	CcSEcCtD
Degarelix—Eye disorder—Epirubicin—testicular cancer	0.000105	0.00111	CcSEcCtD
Degarelix—Hypersensitivity—Etoposide—testicular cancer	0.000105	0.00111	CcSEcCtD
Degarelix—Malnutrition—Methotrexate—testicular cancer	0.000104	0.00111	CcSEcCtD
Degarelix—Erythema—Methotrexate—testicular cancer	0.000104	0.00111	CcSEcCtD
Degarelix—Cardiac disorder—Epirubicin—testicular cancer	0.000104	0.00111	CcSEcCtD
Degarelix—Hypoaesthesia—Doxorubicin—testicular cancer	0.000103	0.0011	CcSEcCtD
Degarelix—Urinary tract disorder—Doxorubicin—testicular cancer	0.000103	0.00109	CcSEcCtD
Degarelix—Oedema peripheral—Doxorubicin—testicular cancer	0.000102	0.00109	CcSEcCtD
Degarelix—Asthenia—Etoposide—testicular cancer	0.000102	0.00108	CcSEcCtD
Degarelix—Angiopathy—Epirubicin—testicular cancer	0.000102	0.00108	CcSEcCtD
Degarelix—Urethral disorder—Doxorubicin—testicular cancer	0.000102	0.00108	CcSEcCtD
Degarelix—Immune system disorder—Epirubicin—testicular cancer	0.000101	0.00108	CcSEcCtD
Degarelix—Mediastinal disorder—Epirubicin—testicular cancer	0.000101	0.00108	CcSEcCtD
Degarelix—Back pain—Methotrexate—testicular cancer	0.000101	0.00107	CcSEcCtD
Degarelix—Chills—Epirubicin—testicular cancer	0.000101	0.00107	CcSEcCtD
Degarelix—Pruritus—Etoposide—testicular cancer	0.000101	0.00107	CcSEcCtD
Degarelix—Arrhythmia—Epirubicin—testicular cancer	0.0001	0.00107	CcSEcCtD
Degarelix—Alopecia—Epirubicin—testicular cancer	9.92e-05	0.00105	CcSEcCtD
Degarelix—Vomiting—Cisplatin—testicular cancer	9.88e-05	0.00105	CcSEcCtD
Degarelix—Vision blurred—Methotrexate—testicular cancer	9.85e-05	0.00105	CcSEcCtD
Degarelix—Mental disorder—Epirubicin—testicular cancer	9.84e-05	0.00105	CcSEcCtD
Degarelix—Rash—Cisplatin—testicular cancer	9.8e-05	0.00104	CcSEcCtD
Degarelix—Dermatitis—Cisplatin—testicular cancer	9.79e-05	0.00104	CcSEcCtD
Degarelix—Malnutrition—Epirubicin—testicular cancer	9.78e-05	0.00104	CcSEcCtD
Degarelix—Erythema—Epirubicin—testicular cancer	9.78e-05	0.00104	CcSEcCtD
Degarelix—Diarrhoea—Etoposide—testicular cancer	9.74e-05	0.00103	CcSEcCtD
Degarelix—Eye disorder—Doxorubicin—testicular cancer	9.71e-05	0.00103	CcSEcCtD
Degarelix—Ill-defined disorder—Methotrexate—testicular cancer	9.69e-05	0.00103	CcSEcCtD
Degarelix—Anaemia—Methotrexate—testicular cancer	9.66e-05	0.00103	CcSEcCtD
Degarelix—Cardiac disorder—Doxorubicin—testicular cancer	9.64e-05	0.00102	CcSEcCtD
Degarelix—Back pain—Epirubicin—testicular cancer	9.46e-05	0.001	CcSEcCtD
Degarelix—Angiopathy—Doxorubicin—testicular cancer	9.43e-05	0.001	CcSEcCtD
Degarelix—Malaise—Methotrexate—testicular cancer	9.42e-05	0.001	CcSEcCtD
Degarelix—Dizziness—Etoposide—testicular cancer	9.41e-05	0.001	CcSEcCtD
Degarelix—Muscle spasms—Epirubicin—testicular cancer	9.4e-05	0.000998	CcSEcCtD
Degarelix—Immune system disorder—Doxorubicin—testicular cancer	9.39e-05	0.000997	CcSEcCtD
Degarelix—Mediastinal disorder—Doxorubicin—testicular cancer	9.37e-05	0.000995	CcSEcCtD
Degarelix—Chills—Doxorubicin—testicular cancer	9.32e-05	0.00099	CcSEcCtD
Degarelix—Arrhythmia—Doxorubicin—testicular cancer	9.28e-05	0.000986	CcSEcCtD
Degarelix—Nausea—Cisplatin—testicular cancer	9.23e-05	0.00098	CcSEcCtD
Degarelix—Vision blurred—Epirubicin—testicular cancer	9.21e-05	0.000979	CcSEcCtD
Degarelix—Alopecia—Doxorubicin—testicular cancer	9.18e-05	0.000975	CcSEcCtD
Degarelix—Mental disorder—Doxorubicin—testicular cancer	9.1e-05	0.000967	CcSEcCtD
Degarelix—Ill-defined disorder—Epirubicin—testicular cancer	9.07e-05	0.000963	CcSEcCtD
Degarelix—Vomiting—Etoposide—testicular cancer	9.05e-05	0.000961	CcSEcCtD
Degarelix—Erythema—Doxorubicin—testicular cancer	9.05e-05	0.000961	CcSEcCtD
Degarelix—Malnutrition—Doxorubicin—testicular cancer	9.05e-05	0.000961	CcSEcCtD
Degarelix—Anaemia—Epirubicin—testicular cancer	9.04e-05	0.00096	CcSEcCtD
Degarelix—Rash—Etoposide—testicular cancer	8.98e-05	0.000953	CcSEcCtD
Degarelix—Dermatitis—Etoposide—testicular cancer	8.97e-05	0.000952	CcSEcCtD
Degarelix—Headache—Etoposide—testicular cancer	8.92e-05	0.000947	CcSEcCtD
Degarelix—Arthralgia—Methotrexate—testicular cancer	8.89e-05	0.000945	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	8.83e-05	0.000938	CcSEcCtD
Degarelix—Malaise—Epirubicin—testicular cancer	8.82e-05	0.000936	CcSEcCtD
Degarelix—Discomfort—Methotrexate—testicular cancer	8.79e-05	0.000933	CcSEcCtD
Degarelix—Back pain—Doxorubicin—testicular cancer	8.75e-05	0.000929	CcSEcCtD
Degarelix—Muscle spasms—Doxorubicin—testicular cancer	8.7e-05	0.000924	CcSEcCtD
Degarelix—Palpitations—Epirubicin—testicular cancer	8.64e-05	0.000918	CcSEcCtD
Degarelix—Anaphylactic shock—Methotrexate—testicular cancer	8.53e-05	0.000906	CcSEcCtD
Degarelix—Vision blurred—Doxorubicin—testicular cancer	8.53e-05	0.000905	CcSEcCtD
Degarelix—Nausea—Etoposide—testicular cancer	8.46e-05	0.000898	CcSEcCtD
Degarelix—Hypertension—Epirubicin—testicular cancer	8.44e-05	0.000896	CcSEcCtD
Degarelix—Ill-defined disorder—Doxorubicin—testicular cancer	8.39e-05	0.000891	CcSEcCtD
Degarelix—Nervous system disorder—Methotrexate—testicular cancer	8.36e-05	0.000888	CcSEcCtD
Degarelix—Anaemia—Doxorubicin—testicular cancer	8.36e-05	0.000888	CcSEcCtD
Degarelix—Arthralgia—Epirubicin—testicular cancer	8.32e-05	0.000884	CcSEcCtD
Degarelix—Skin disorder—Methotrexate—testicular cancer	8.28e-05	0.00088	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	8.27e-05	0.000878	CcSEcCtD
Degarelix—Hyperhidrosis—Methotrexate—testicular cancer	8.24e-05	0.000875	CcSEcCtD
Degarelix—Discomfort—Epirubicin—testicular cancer	8.22e-05	0.000873	CcSEcCtD
Degarelix—Malaise—Doxorubicin—testicular cancer	8.16e-05	0.000866	CcSEcCtD
Degarelix—Dry mouth—Epirubicin—testicular cancer	8.14e-05	0.000865	CcSEcCtD
Degarelix—Palpitations—Doxorubicin—testicular cancer	7.99e-05	0.000849	CcSEcCtD
Degarelix—Anaphylactic shock—Epirubicin—testicular cancer	7.98e-05	0.000847	CcSEcCtD
Degarelix—Hypotension—Methotrexate—testicular cancer	7.97e-05	0.000846	CcSEcCtD
Degarelix—Nervous system disorder—Epirubicin—testicular cancer	7.83e-05	0.000831	CcSEcCtD
Degarelix—Hypertension—Doxorubicin—testicular cancer	7.81e-05	0.000829	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Methotrexate—testicular cancer	7.77e-05	0.000825	CcSEcCtD
Degarelix—Skin disorder—Epirubicin—testicular cancer	7.75e-05	0.000823	CcSEcCtD
Degarelix—Hyperhidrosis—Epirubicin—testicular cancer	7.71e-05	0.000819	CcSEcCtD
Degarelix—Insomnia—Methotrexate—testicular cancer	7.71e-05	0.000819	CcSEcCtD
Degarelix—Arthralgia—Doxorubicin—testicular cancer	7.7e-05	0.000818	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	7.65e-05	0.000812	CcSEcCtD
Degarelix—Discomfort—Doxorubicin—testicular cancer	7.61e-05	0.000808	CcSEcCtD
Degarelix—Dyspnoea—Methotrexate—testicular cancer	7.6e-05	0.000807	CcSEcCtD
Degarelix—Dry mouth—Doxorubicin—testicular cancer	7.53e-05	0.0008	CcSEcCtD
Degarelix—Hypotension—Epirubicin—testicular cancer	7.46e-05	0.000792	CcSEcCtD
Degarelix—Decreased appetite—Methotrexate—testicular cancer	7.41e-05	0.000787	CcSEcCtD
Degarelix—Anaphylactic shock—Doxorubicin—testicular cancer	7.38e-05	0.000784	CcSEcCtD
Degarelix—Gastrointestinal disorder—Methotrexate—testicular cancer	7.36e-05	0.000782	CcSEcCtD
Degarelix—Fatigue—Methotrexate—testicular cancer	7.35e-05	0.000781	CcSEcCtD
Degarelix—Pain—Methotrexate—testicular cancer	7.29e-05	0.000774	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Epirubicin—testicular cancer	7.27e-05	0.000772	CcSEcCtD
Degarelix—Nervous system disorder—Doxorubicin—testicular cancer	7.24e-05	0.000769	CcSEcCtD
Degarelix—Insomnia—Epirubicin—testicular cancer	7.22e-05	0.000766	CcSEcCtD
Degarelix—Skin disorder—Doxorubicin—testicular cancer	7.17e-05	0.000762	CcSEcCtD
Degarelix—Hyperhidrosis—Doxorubicin—testicular cancer	7.14e-05	0.000758	CcSEcCtD
Degarelix—Dyspnoea—Epirubicin—testicular cancer	7.11e-05	0.000756	CcSEcCtD
Degarelix—Feeling abnormal—Methotrexate—testicular cancer	7.03e-05	0.000746	CcSEcCtD
Degarelix—Gastrointestinal pain—Methotrexate—testicular cancer	6.97e-05	0.00074	CcSEcCtD
Degarelix—Decreased appetite—Epirubicin—testicular cancer	6.94e-05	0.000737	CcSEcCtD
Degarelix—Hypotension—Doxorubicin—testicular cancer	6.9e-05	0.000733	CcSEcCtD
Degarelix—Gastrointestinal disorder—Epirubicin—testicular cancer	6.89e-05	0.000732	CcSEcCtD
Degarelix—Fatigue—Epirubicin—testicular cancer	6.88e-05	0.000731	CcSEcCtD
Degarelix—Pain—Epirubicin—testicular cancer	6.82e-05	0.000725	CcSEcCtD
Degarelix—Constipation—Epirubicin—testicular cancer	6.82e-05	0.000725	CcSEcCtD
Degarelix—Urticaria—Methotrexate—testicular cancer	6.77e-05	0.000719	CcSEcCtD
Degarelix—Body temperature increased—Methotrexate—testicular cancer	6.74e-05	0.000716	CcSEcCtD
Degarelix—Abdominal pain—Methotrexate—testicular cancer	6.74e-05	0.000716	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Doxorubicin—testicular cancer	6.73e-05	0.000714	CcSEcCtD
Degarelix—Insomnia—Doxorubicin—testicular cancer	6.68e-05	0.000709	CcSEcCtD
Degarelix—Dyspnoea—Doxorubicin—testicular cancer	6.58e-05	0.000699	CcSEcCtD
Degarelix—Feeling abnormal—Epirubicin—testicular cancer	6.58e-05	0.000698	CcSEcCtD
Degarelix—Gastrointestinal pain—Epirubicin—testicular cancer	6.53e-05	0.000693	CcSEcCtD
Degarelix—Decreased appetite—Doxorubicin—testicular cancer	6.42e-05	0.000682	CcSEcCtD
Degarelix—Gastrointestinal disorder—Doxorubicin—testicular cancer	6.37e-05	0.000677	CcSEcCtD
Degarelix—Fatigue—Doxorubicin—testicular cancer	6.37e-05	0.000676	CcSEcCtD
Degarelix—Urticaria—Epirubicin—testicular cancer	6.34e-05	0.000673	CcSEcCtD
Degarelix—Pain—Doxorubicin—testicular cancer	6.31e-05	0.000671	CcSEcCtD
Degarelix—Constipation—Doxorubicin—testicular cancer	6.31e-05	0.000671	CcSEcCtD
Degarelix—Abdominal pain—Epirubicin—testicular cancer	6.31e-05	0.00067	CcSEcCtD
Degarelix—Body temperature increased—Epirubicin—testicular cancer	6.31e-05	0.00067	CcSEcCtD
Degarelix—Hypersensitivity—Methotrexate—testicular cancer	6.28e-05	0.000667	CcSEcCtD
Degarelix—Asthenia—Methotrexate—testicular cancer	6.12e-05	0.00065	CcSEcCtD
Degarelix—Feeling abnormal—Doxorubicin—testicular cancer	6.08e-05	0.000646	CcSEcCtD
Degarelix—Gastrointestinal pain—Doxorubicin—testicular cancer	6.04e-05	0.000641	CcSEcCtD
Degarelix—Pruritus—Methotrexate—testicular cancer	6.03e-05	0.000641	CcSEcCtD
Degarelix—Hypersensitivity—Epirubicin—testicular cancer	5.88e-05	0.000624	CcSEcCtD
Degarelix—Urticaria—Doxorubicin—testicular cancer	5.87e-05	0.000623	CcSEcCtD
Degarelix—Abdominal pain—Doxorubicin—testicular cancer	5.84e-05	0.00062	CcSEcCtD
Degarelix—Body temperature increased—Doxorubicin—testicular cancer	5.84e-05	0.00062	CcSEcCtD
Degarelix—Diarrhoea—Methotrexate—testicular cancer	5.83e-05	0.00062	CcSEcCtD
Degarelix—Asthenia—Epirubicin—testicular cancer	5.73e-05	0.000608	CcSEcCtD
Degarelix—Pruritus—Epirubicin—testicular cancer	5.65e-05	0.0006	CcSEcCtD
Degarelix—Dizziness—Methotrexate—testicular cancer	5.64e-05	0.000599	CcSEcCtD
Degarelix—Diarrhoea—Epirubicin—testicular cancer	5.46e-05	0.00058	CcSEcCtD
Degarelix—Hypersensitivity—Doxorubicin—testicular cancer	5.44e-05	0.000578	CcSEcCtD
Degarelix—Vomiting—Methotrexate—testicular cancer	5.42e-05	0.000576	CcSEcCtD
Degarelix—Rash—Methotrexate—testicular cancer	5.38e-05	0.000571	CcSEcCtD
Degarelix—Dermatitis—Methotrexate—testicular cancer	5.37e-05	0.00057	CcSEcCtD
Degarelix—Headache—Methotrexate—testicular cancer	5.34e-05	0.000567	CcSEcCtD
Degarelix—Asthenia—Doxorubicin—testicular cancer	5.3e-05	0.000563	CcSEcCtD
Degarelix—Dizziness—Epirubicin—testicular cancer	5.28e-05	0.00056	CcSEcCtD
Degarelix—Pruritus—Doxorubicin—testicular cancer	5.22e-05	0.000555	CcSEcCtD
Degarelix—Vomiting—Epirubicin—testicular cancer	5.07e-05	0.000539	CcSEcCtD
Degarelix—Nausea—Methotrexate—testicular cancer	5.06e-05	0.000538	CcSEcCtD
Degarelix—Diarrhoea—Doxorubicin—testicular cancer	5.05e-05	0.000537	CcSEcCtD
Degarelix—Rash—Epirubicin—testicular cancer	5.03e-05	0.000534	CcSEcCtD
Degarelix—Dermatitis—Epirubicin—testicular cancer	5.03e-05	0.000534	CcSEcCtD
Degarelix—Headache—Epirubicin—testicular cancer	5e-05	0.000531	CcSEcCtD
Degarelix—Dizziness—Doxorubicin—testicular cancer	4.88e-05	0.000519	CcSEcCtD
Degarelix—Nausea—Epirubicin—testicular cancer	4.74e-05	0.000503	CcSEcCtD
Degarelix—Vomiting—Doxorubicin—testicular cancer	4.69e-05	0.000499	CcSEcCtD
Degarelix—Rash—Doxorubicin—testicular cancer	4.66e-05	0.000494	CcSEcCtD
Degarelix—Dermatitis—Doxorubicin—testicular cancer	4.65e-05	0.000494	CcSEcCtD
Degarelix—Headache—Doxorubicin—testicular cancer	4.63e-05	0.000491	CcSEcCtD
Degarelix—Nausea—Doxorubicin—testicular cancer	4.39e-05	0.000466	CcSEcCtD
